graph EGM comparisons
pembrolizumab (10mg/kg)titlepembrolizumab (2mg/kg)titledocetaxeltitleKEYNOTE-010 (P:10 mg/kg), 2016 NCT01905657 mNSCLC - L2 - PDL1 positive 346/343KEYNOTE-010 (P:10 mg/kg ; PDL1>50%), 2016 NCT01905657 mNSCLC - L2 - PDL1 positive 151/152KEYNOTE-010 (P: 2mg/kg ; PDL1>50%), 2016 NCT01905657 mNSCLC - L2 - PDL1 positive 139/152KEYNOTE-010 (P: 2mg/kg), 2016 NCT01905657 mNSCLC - L2 - PDL1 positive 344/343

Pathology:  mNSCLC - L2 - PDL1 positive; 

mNSCLC - L2 - PDL1 positive
KEYNOTE-010 (P:10 mg/kg), 2016KEYNOTE-010 (P:10 mg/kg ; PDL1>50%), 2016KEYNOTE-010 (P: 2mg/kg ; PDL1>50%), 2016KEYNOTE-010 (P: 2mg/kg), 2016
pembrolizumab (10mg/kg)2T1T1
pembrolizumab (2mg/kg)2T1T1
docetaxel0T0T0T0T0